Benzinga's Top Upgrades

Analysts at BMO Capital upgraded Eli Lilly and Company

from “underperform” to “market perform.” The target price for Eli Lilly has been raised from $50 to $62. Eli Lilly's shares closed at $58.62 yesterday. Analysts at BMO Capital upgraded Mallinckrodt PLC

from “market perform” to “outperform.” The target price for Mallinckrodt has been raised from $70 to $71. Mallinckrodt's shares closed at $60.95 yesterday. Raymond James upgraded CACI International

from “underperform” to “outperform.” The target price for CACI International is set to $80. CACI International's shares closed at $69.69 yesterday. Analysts at Stifel Nicolaus upgraded Nike

from “hold” to “buy.” The target price for Nike is set to $87. Nike's shares closed at $70.83 yesterday.